Prevent-Plus, a St. Louis biotech company, manufactures and markets Preventogen, an FDA-cleared Class I medical device that uses a non-antibiotic microbicidal liquid polymer to protect wounds and surgical sites. Developed through a collaboration between research scientist Joseph Sant’Angelo and NYU dermatology professor Perry Robins, the polymer kills microbes on contact before drying into a flexible barrier that helps shield the area during healing. The company’s clinical work includes surgical, dialysis-catheter, external-fixation and diabetic-foot-ulcer applications, with the product made in the United States.
FDA 510(k) Clearance, Class I Medical Device
certification
ISO 13485:2016
certification
ISO 9001:2015
certification